As calls for COINS Act expansion grow, will new rules sweep up China biotech licensing?

Amid an intensifying debate over how Washington should counter China’s rapid ascent in the biotech sector, a growing chorus of policymakers and biotech insiders is urging the Treasury Department to expand the newly codified COINS Act to include biotechnology—a move that would extend outbound investm